NUZ 2.50% 19.5¢ neurizon therapeutics limited

Ann: Resignation of Epichem CEO, page-22

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,964 Posts.
    lightbulb Created with Sketch. 1748
    Again you try and twist my words, so I shall repeat this, I didnt use the words cutting edge, what I said that it wasn't new research because it has been ongoing for 30 years.
    As for progress:
    What progress has been made in human cancer since 2015/16 in human cancer, well we were told they needed to wait for data from canine cancer trials which they now have had for over 9 months but no trials locked in until later this year, so to me they no nothing more about how mpl works on human cancers then they did back in 201 / 2016
    CovidSo
    What did they do with the data from two trials at WEHI, they needed to go and get 360Labs data but still not happy with this they then proceeded to Leiden.
    So do we know if mpl actually works in humans no we don't

    Canine cancers
    After the so called end of phase 2b canine trials it was announced they were moving to phase 3 trials but have they no, they now are going to continue with phase 2b in NZ.


    So if they announce something then don't carry through with it what would you call it, I call it spin

 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.005(2.50%)
Mkt cap ! $94.89M
Open High Low Value Volume
20.0¢ 20.3¢ 19.5¢ $124.5K 628.4K

Buyers (Bids)

No. Vol. Price($)
2 2791 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 62424 2
View Market Depth
Last trade - 15.39pm 01/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.